Asia-Pacific metabolic disorder therapeutics market is estimated to grow at a CAGR of 8.2% during the forecast period. The rising prevalence of metabolic disorders and increasing awareness regarding health is driving the demand for metabolic disorder therapeutics in the region. As per the World Bank, in China, the prevalence of diabetes among the population ages 20-79 was 9.2% in 2019. It is growing significantly due to sedentary lifestyle habits. In India, the prevalence of diabetes was found to be 11.8% in people above the age of 50.
Please read the originial post here: https://www.omrglobal.com/industry-reports/asia-pacific-metabolic-disorder-therapeutics-market